The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma: A BEACON-Neuroblastoma biomarker study.
 
Lucas Moreno
Honoraria - Bayer (Inst); EUSA Pharma (Inst)
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Norgine (Inst); Novartis (Inst); Shionogi (Inst)
Patents, Royalties, Other Intellectual Property - Member of SIOPEN Executive Committee, SIOPEN receives royalties for the sales of dinutuximab beta (Inst)
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc (Inst)
 
Rebekah Weston
No Relationships to Disclose
 
Virginie Viprey
No Relationships to Disclose
 
Andrei Tchirkov
No Relationships to Disclose
 
Maria Corrias
No Relationships to Disclose
 
Tim Lammens
No Relationships to Disclose
 
Juliet Gray
Consulting or Advisory Role - EUSA Pharma; Norgine; YmAbs Therapeutics Inc
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
Patents, Royalties, Other Intellectual Property - Patent #20210346498
Travel, Accommodations, Expenses - EUSA Pharma
 
Cormac Owens
No Relationships to Disclose
 
Jennifer Laidler
No Relationships to Disclose
 
Marion Gambart
No Relationships to Disclose
 
Victoria Castel
No Relationships to Disclose
 
Natasha Van Eijkelenburg
Speakers' Bureau - EUSA Pharma
 
Karsten Nysom
Honoraria - Y-mAbs Therapeutics
Consulting or Advisory Role - Bayer; EUSA Pharma; Ymabs Therapeutics Inc
Travel, Accommodations, Expenses - Bayer
 
Genevieve Laureys
No Relationships to Disclose
 
Aurora Castellano
No Relationships to Disclose
 
Nicolas U. Gerber
No Relationships to Disclose
 
Ruth Lydia Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics; EUSA Pharma
Travel, Accommodations, Expenses - Apeiron Biologics; EUSA Pharma
 
Dominique Valteau Couanet
Consulting or Advisory Role - EUSA Pharma (Inst)
Research Funding - Orphelia Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Apeiron to SIOPEN (Inst)
Travel, Accommodations, Expenses - EUSA Pharma; Jazz Pharmaceuticals
 
Keith Wheatley
Research Funding - Bayer (Inst); Bio-Cancer Treatment International (Inst); EUSA Pharma (Inst); Roche (Inst)
 
Susan A Burchill
No Relationships to Disclose